Xeris Pharmaceuticals | XERS - Market Capitalization


Xeris Pharmaceuticals reported $1.22B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Celltrion KRW 37.87T 35.44T Jul/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 2.71B 1.87B Jul/2026
Divis Laboratories Ltd INR 1.58T 118.27B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Nektar Therapeutics USD 12.82B 11.96B Jul/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 136.51M 115.96M Jul/2026
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.31B 604M Mar/2026
Pharma Mar EUR 1.57B 225M Mar/2026
Qiagen NV USD 8.27B 1.62B Mar/2026
Sartorius EUR 14.25B 2.16B Mar/2026
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026
Zealand Pharma A/S 33.35B 448.34M Dec/2025